Randomized, exploratory, open, phase IV, blinded (PROBE design), multicentre and prospective study to comparatively evaluate the effect of adding esmolol in the current therapeutic scheme used for the treatment of Hemorrhagic Stroke.
Further information:https://clinicaltrials.gov/ct2/show/NCT03743103?term=ETHICHS&cond=Stroke&draw=2&rank=1